SRGAP3-LHFPL4 Fusion FISH Probe
The SRGAP3-LHFPL4 Fusion FISH Probe is used to confirm a fusion of the SRGAP3 and LHFPL4 genes. The fusion of the SRGAP3 and LHFPL4 genes has been associated with Uterine Corpus Endometrial Carcinoma, Uterine Corpus Endometrial Carcinoma, and Uterine Corpus Endometrial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| SRGAP3-LHFPL4-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-RERE | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-REOR | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-REGO | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-REGR | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-OROR | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-GORE | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-GROR | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| SRGAP3-LHFPL4-20-AQAQ | 20 (40 μL) | 200 μL |
|
SRGAP3 Gene Summary
The SLIT-ROBO Rho GTPase Activating Protein 3 (SRGAP3) gene is located on chr3 :9022277-9291311 at 3p25.3.
Gene Name: SLIT-ROBO Rho GTPase Activating Protein 3
Chromosome: CHR3: 9022277 -9291311
Locus: 3p25.3
LHFPL4 Gene Summary
This gene is a member of the lipoma HMGIC fusion partner (LHFP) gene family, which is a subset of the superfamily of tetraspan transmembrane protein encoding genes. Mutations in one LHFP-like gene result in deafness in humans and mice, and a second LHFP-like gene is fused to a high-mobility group gene in a translocation-associated lipoma. [provided by RefSeq, Jul 2008]
Gene Name: LHFPL Tetraspan Subfamily Member 4
Chromosome: CHR3: 9540044 -9595486
Locus: 3p25.3
Gene Diseases
The SRGAP3 LHFPL4 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Corpus Endometrial Carcinoma |
| Uterine Corpus Endometrial Carcinoma |
| Uterine Corpus Endometrial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|